InClin, Inc is a full service Contract Research Organization established in 1998 with offices in the San Francisco Bay Area and Sydney, Australia. The company offers integrated clinical development services from Phase 1 through Phase 4, including project management, clinical monitoring, site and contract management, data management, biostatistics, programming, and more. With a track record of completing over 400 trials, including 9 NDAs, 1 sNDA, and 2 BLAs, InClin stands out for its on-time and on-budget trials.
The company's strength lies in its experienced staff with an average of 20+ years of clinical research experience and a high retention rate. InClin emphasizes building solid partnerships with over 150 Sponsor companies and provides strategic consulting services. The senior management team's multidisciplinary training enables them to design and execute sound clinical programs, emphasizing Quality Assurance to ensure full compliance with regulatory standards.
InClin's unique approach is reflected in its investment in employees, through training and development, enabling efficient operationalization of clinical trials with high-quality deliverables. The company prides itself on proactive and transparent communication with sponsors, ensuring confidence in the study's progress and budget adherence. In summary, InClin's dedication to quality, experienced team, and strong partnerships make it an attractive investment opportunity for venture capitalists seeking exposure to the contract research and clinical development industry.